Keyphrases
Gene Therapy
100%
AAV Vector
100%
Duchenne muscular Dystrophy
100%
Mdx Mice
75%
Skeletal muscle
62%
Dystrophic muscle
50%
Dystrophin
50%
Muscular Dystrophy
37%
Integrin
37%
Cardiac muscle
25%
Ligand-binding Domain
25%
Dystrophic
25%
Muscle Tissue
25%
Integrin Binding
25%
Human Trials
25%
Therapeutic Testing
25%
Developmental Research
25%
Gene Delivery
25%
Progressive Myopathies
25%
Large Animal Model
25%
Delivery Efficiency
25%
Therapeutic Use
25%
Premature Death
25%
Translational Research
12%
AAV2
12%
Intramuscular Delivery
12%
Capsid
12%
Developmental Phases
12%
Clinical Trials
12%
Overexpression
12%
Genetic Replacement
12%
Special Design
12%
Directed Evolution
12%
High Efficiency
12%
Exploratory Phase
12%
Route of Administration
12%
Rational Engineering
12%
Peptide Ligand
12%
Combinatorial Engineering
12%
Mutant Library
12%
Design Strategy
12%
Medicine and Dentistry
Adeno Associated Virus Vector
100%
Gene Therapy
100%
Duchenne Muscular Dystrophy
100%
Skeletal Muscle
62%
Integrin
62%
Dystrophin
50%
Clinical Trial
37%
Transgene
37%
Muscular Dystrophy
37%
Gene Targeting
25%
Myopathy
25%
Cardiac Muscle
25%
Prematurity
25%
Virus Capsid
12%
Adeno-Associated Virus
12%
Translational Research
12%
Research Design
12%
Biochemistry, Genetics and Molecular Biology
Adeno Associated Virus Vector
100%
Gene Therapy
100%
Integrin
62%
Mouse Model
50%
Dystrophin
50%
Clinical Trial
37%
Transgene
37%
Skeletal Muscle
37%
Mouse
25%
Gene Targeting
25%
Binding Domain
25%
Animal Model
25%
Capsid
12%
Genetics
12%